Print Page | Sign In | Join
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

Displaying page 23 of 27
 |<   <<   <  18  |  19  |  20  |  21  |  22  |  23  |  24  |  25  |  26  |  27

Scientific Advancements
Wednesday, June 27, 2018   (0 Comments - view/add)
Boca Raton Regional Hospital One Of Four Sites Nationally In "Breakthrough Therapy" Clinical Trial »
Boca Raton Regional Hospital One Of Four Sites Nationally In "Breakthrough Therapy" Clinical Trial Marcus Neuroscience...
Thursday, June 21, 2018   (0 Comments - view/add)
Medtronic Receives FDA Approval of New Pediatric Indication for the MiniMed(TM) 670G Hybrid Closed L »
Medtronic Receives FDA Approval of New Pediatric Indication for the MiniMed(TM) 670G Hybrid Closed Loop System in Children...
Monday, June 18, 2018   (0 Comments - view/add)
Dyadic International Improves Monoclonal Antibody (mAb) Productivity Utilizing C1 Gene Expression Pl »
Dyadic International Improves Monoclonal Antibody (mAb) Productivity Utilizing C1 Gene Expression Platform to Manufacture...
Wednesday, June 13, 2018   (0 Comments - view/add)
Oragenics, Inc. Announces Peer-Reviewed Publication Detailing Discovery of OG716 for C. difficile in »
Oragenics, Inc. Announces Peer-Reviewed Publication Detailing Discovery of OG716 for C. difficile infections...
Tuesday, June 12, 2018   (0 Comments - view/add)
RTI Surgical® Announces Commercial Launch of Fortilink®-TS and -L IBF Systems with TETRAfuse® 3D Tec »
RTI Surgical® Announces Commercial Launch of Fortilink®-TS and -L IBF Systems with TETRAfuse® 3D Technology...
Monday, June 11, 2018   (0 Comments - view/add)
UCF Study: Orange Peels May Hold Secret to Airborne Medicine, Safer Bridges »
UNIVERSITY OF CENTRAL FLORIDA   Orange Peels May Hold Secret to Airborne Medicine, Safer Bridges  ...
Thursday, June 7, 2018   (0 Comments - view/add)
New UCF Sensor Can Determine if Molecules are Left or Right ‘Handed’ »
New UCF Sensor Can Determine if Molecules are Left or Right ‘Handed’ Researchers Create New Optical Technique to Dete...
Tuesday, June 5, 2018   (0 Comments - view/add)
Dyadic to Develop Biosimilars Using CHO-Challenging Expression System »
BioProcess International by Dan Stanton, Tuesday, June 5, 2018 Dyadic to Develop Biosimilars Using CHO-Challengin...
Wednesday, May 30, 2018   (0 Comments - view/add)
TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXY (estradiol vaginal inserts), the Lowest D »
TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXY (estradiol vaginal inserts), the Lowest Dose Vaginal Estrogen P...
Wednesday, May 23, 2018   (0 Comments - view/add)
TD Solutions Announces Epi Mist™ HypoSpray® Epinephrine »
May 22, 2018   TD Solutions Announces Epi Mist™ HypoSpray® Epinephrine   TD Solutions, a...
Tuesday, May 22, 2018   (0 Comments - view/add)
TD Solutions Announces Levellor™ HypoSpray® Insulin »
May 22, 2018 TD Solutions Announces Levellor™ HypoSpray® Insulin   TD Solutions, a lead...
Friday, May 18, 2018   (0 Comments - view/add)
Prevacus Partners with BrainScope for Upcoming Drug Study on Concussion »
Prevacus Partners with BrainScope for Upcoming Drug Study on Concussion TALLAHASSEE, Fla. , May 18, 2018 /PRNewsw...
Thursday, April 26, 2018   (0 Comments - view/add)
Human-on-a-chip Company Hesperos Licenses First Functional Stem-Cell Derived Neuromuscular Junction »
Human-on-a-chip Company Hesperos Licenses First Functional Stem-Cell Derived Neuromuscular Junction Model Innova...
Thursday, April 19, 2018   (0 Comments - view/add)
Catalyst Pharmaceuticals Announces Enrollment of First Patient in Phase 3 Trial of Firdapse® in MuSK »
Catalyst Pharmaceuticals Announces Enrollment of First Patient in Phase 3 Trial of Firdapse® in MuSK Antibody Positive Mya...
Wednesday, April 18, 2018   (0 Comments - view/add)
AGTC Doses First Patient in Phase 1/2 Clinical Study of Gene Therapy for the Treatment of X-Linked R »
AGTC Doses First Patient in Phase 1/2 Clinical Study of Gene Therapy for the Treatment of X-Linked Retinitis Pigmentosa...
Tuesday, April 10, 2018   (0 Comments - view/add)
AGTC Announces Completion of Enrollment of Phase 1 / 2 Clinical Study of Investigational Gene Therap »
AGTC Announces Completion of Enrollment of Phase 1 / 2 Clinical Study of Investigational Gene Therapy in Patients with X-l...
Thursday, March 29, 2018   (0 Comments - view/add)
CTD Holdings Conducts Initial Review of Safety Data for its Phase I and Phase I/II Trials of Trappso »
CTD Holdings Conducts Initial Review of Safety Data for its Phase I and Phase I/II Trials of Trappsol(R) Cyclo(TM) to Trea...
Thursday, March 29, 2018   (0 Comments - view/add)
Catalyst Pharmaceuticals Announces Submission of New Drug Application for Firdapse® for Treatment of »
Catalyst Pharmaceuticals Announces Submission of New Drug Application for Firdapse® for Treatment of Lambert-Eaton Myasthe...
Wednesday, March 28, 2018   (0 Comments - view/add)
Data Showcasing Strength of RTI’s SImmetry® System in Sacroiliac Joint Fusion Published in The Spine »
Data Showcasing Strength of RTI’s SImmetry® System in Sacroiliac Joint Fusion Published in The Spine Journal S...
Friday, March 23, 2018   (0 Comments - view/add)
Oragenics Completes Enrollment for the Interim Analysis Cohort in Its Phase 2 Clinical Trial of AG01 »
Oragenics Completes Enrollment for the Interim Analysis Cohort in Its Phase 2 Clinical Trial of AG013 for Oral Mucositis...
Tuesday, March 20, 2018   (0 Comments - view/add)
KemPharm Announces Positive Topline Results from KP415 Pharmacokinetic Study in Children and Adolesc »
KemPharm Announces Positive Topline Results from KP415 Pharmacokinetic Study in Children and Adolescents With ADHD &...
Monday, March 19, 2018   (0 Comments - view/add)
Oragenics, Inc. Announces Peer Reviewed Publication Examining Efficacy of Mutacin 1140 Lantibiotic V »
Oragenics, Inc. Announces Peer Reviewed Publication Examining Efficacy of Mutacin 1140 Lantibiotic Variants against Clost...
Friday, March 16, 2018   (0 Comments - view/add)
Intezyne Partners with Exosome Diagnostics on IT-139 Companion Diagnostic »
Intezyne Partners with Exosome Diagnostics on IT-139 Companion Diagnostic   TAMPA, Fla., March 16, 20...
Thursday, March 15, 2018   (0 Comments - view/add)
TapImmune Announces Publication of Clinical Trial Results for the TPIV200 Cancer Vaccine in Clinical »
TapImmune Announces Publication of Clinical Trial Results for the TPIV200 Cancer Vaccine in Clinical Cancer Research &n...
Wednesday, March 14, 2018   (0 Comments - view/add)
Jupiter Orphan Therapeutics Announces Submission of Investigational New Drug Application (IND) For T »
Jupiter Orphan Therapeutics Announces Submission of Investigational New Drug Application (IND) For Treatment Of Mucopolysa...
Monday, March 12, 2018   (0 Comments - view/add)
Publication in Blood Advances® Reports that the Combination of Cantex Pharmaceuticals' CX-01 with Ch »
Publication in Blood Advances® Reports that the Combination of Cantex Pharmaceuticals' CX-01 with Chemotherapy for the Tre...
Monday, March 12, 2018   (0 Comments - view/add)
CTD Holdings Announces FDA Authorization to Proceed with Single Patient IND for Use of Trappsol(R) C »
CTD Holdings Announces FDA Authorization to Proceed with Single Patient IND for Use of Trappsol(R) Cyclo(TM) to Treat Alzh...
Thursday, March 8, 2018   (0 Comments - view/add)
TherapeuticsMD Announces FDA Acceptance of New Drug Application (NDA) and Prescription Drug User Fee »
TherapeuticsMD Announces FDA Acceptance of New Drug Application (NDA) and Prescription Drug User Fee Act (PDUFA) Date for...
Monday, March 5, 2018   (0 Comments - view/add)
Fort Walton Beach Medical Center - First Hospital in the Area to Implant the World’s Smallest and Le »
FOR IMMEDIATE RELEASE   Media Contact: Fort Walton Beach Medical Center      &...
Tuesday, February 27, 2018   (0 Comments - view/add)
First Longeveron Mesenchymal Stem Cell Treatment Administered to an Infant with Rare Heart Condition »
First Longeveron Mesenchymal Stem Cell Treatment Administered to an Infant with Rare Heart Condition as Part of Groundbrea...
Tuesday, February 27, 2018   (0 Comments - view/add)
Dyadic International, Inc. Announces Research and Development Collaboration with Mitsubishi Tanabe P »
Dyadic International, Inc. Announces Research and Development Collaboration with Mitsubishi Tanabe Pharma Corporation To P...
Friday, February 23, 2018   (0 Comments - view/add)
KemPharm Announces FDA Approval of Apadaz(TM) (benzhydrocodone and acetaminophen) for the Short-Term »
KemPharm Announces FDA Approval of Apadaz™ (benzhydrocodone and acetaminophen) for the Short-Term Management of Acute Pain...
Wednesday, February 14, 2018   (0 Comments - view/add)
FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults »
FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults New quick testing option...
Tuesday, February 13, 2018   (0 Comments - view/add)
Somahlution Announces Site Initiation and Patient Enrollment in United Kingdom for European DuraGraf »
Somahlution Announces Site Initiation and Patient Enrollment in United Kingdom for European DuraGraft Registry T...
Monday, February 12, 2018   (0 Comments - view/add)
Catalyst Pharmaceuticals Announces Plans to Resubmit New Drug Application for Firdapse® »
Catalyst Pharmaceuticals Announces Plans to Resubmit New Drug Application for Firdapse® Positive meeting with...

Displaying page 23 of 27
 |<   <<   <  18  |  19  |  20  |  21  |  22  |  23  |  24  |  25  |  26  |  27

About BioFlorida

BioFlorida is the voice of Florida's life sciences industry, representing 8,600 establishments and research organizations in the BioPharma, MedTech, Digital Health and Health Systems that collectively employ nearly 107,000 Floridians. Source: TEConomy/BIO (released 2022)